نتایج جستجو برای: rabies neutralizing antibody

تعداد نتایج: 182552  

2017
Tiina Nokireki Miia Jakava-Viljanen Anna-Maija Virtala Liisa Sihvonen

BACKGROUND Rabies is preventable by pre- and/or post-exposure prophylaxis consisting of series of rabies vaccinations and in some cases the use of immunoglobulins. The success of vaccination can be estimated either by measuring virus neutralising antibodies or by challenge experiment. Vaccines based on rabies virus offer cross-protection against other lyssaviruses closely related to rabies viru...

2014
Yuan Fang Li Chen Man-Qing Liu Zheng-Gang Zhu Ze-Rong Zhu Quan Hu

BACKGROUND The aim of this study was to compare the safety and immunogenicity between purified vero cell rabies vaccine (PVRV) and purified chick embryo cell vaccine (PCECV) in patients with WHO category II animal exposure, especially in different age groups. METHODOLOGY/PRINCIPAL FINDINGS In one-year clinical observation after vaccination with PVRV or PCECV under Zagreb (2-1-1) or Essen (1-1...

2011
Thavatchai Kamoltham Wiravan Thinyounyong Pakamatz Khawplod Phran Phraisuwan Phana Phongchamnaphai Gerlind Anders Claudius Malerczyk

Objectives. To assess the immunogenicity of intradermal (ID) booster doses of Purified Chick Embryo Cell rabies vaccine (PCECV, Rabipur) administered to Thai schoolchildren one, three and five years after a primary ID pre-exposure (PrEP) vaccination series. Methods. In this follow-up study of a randomized, open-label, phase II clinical trial, two simulated post-exposure booster doses of PCECV w...

2015
Dong-Kun Yang Ha-Hyun Kim Hyun-Ye Jo Hee-Won Kim Sung-Suk Choi In-Soo Cho

A new alternative rabies bait vaccine strain named ERAG3G, which is applicable to wild animals, was developed to eliminate rabies in South Korea. In this study, the safety and immunogenicity of the strain was evaluated in Korean raccoon dogs. The ERAG3G was propagated in BHK/T7-9 cells. Korean raccoon dogs were administered ERAG3G (1 ml, 10 FAID50/ml) orally or intramuscularly to evaluate its s...

2012
Amy T. Gilbert Brett W. Petersen Sergio Recuenco Michael Niezgoda Jorge Gómez V. Alberto Laguna-Torres Charles Rupprecht

In May of 2010, two communities (Truenococha and Santa Marta) reported to be at risk of vampire bat depredation were surveyed in the Province Datem del Marañón in the Loreto Department of Perú. Risk factors for bat exposure included age less than or equal to 25 years and owning animals that had been bitten by bats. Rabies virus neutralizing antibodies (rVNAs) were detected in 11% (7 of 63) of h...

Journal: :Journal of virology 2011
Jinying Ge Xijun Wang Lihong Tao Zhiyuan Wen Na Feng Songtao Yang Xianzhu Xia Chinglai Yang Hualan Chen Zhigao Bu

Effective, safe, and affordable rabies vaccines are still being sought. Newcastle disease virus (NDV), an avian paramyxovirus, has shown promise as a vaccine vector for mammals. Here, we generated a recombinant avirulent NDV La Sota strain expressing the rabies virus glycoprotein (RVG) and evaluated its potential to serve as a vaccine against rabies. The recombinant virus, rL-RVG, retained its ...

Journal: :Journal of virology 2015
Darryll A Barkhouse Samantha A Garcia Emily K Bongiorno Aurore Lebrun Milosz Faber D Craig Hooper

UNLABELLED Previous animal model experiments have shown a correlation between interferon gamma (IFN-γ) expression and both survival from infection with attenuated rabies virus (RABV) and reduction of neurological sequelae. Therefore, we hypothesized that rapid production of murine IFN-γ by the rabies virus itself would induce a more robust antiviral response than would occur naturally in mice. ...

Journal: :Nature Immunology 2015

2014
Craig J. van Dolleweerd Audrey Y-H. Teh Ashley C. Banyard Leonard Both Hester C. T. Lotter-Stark Tsepo Tsekoa Baby Phahladira Wonderful Shumba Ereck Chakauya Claude T. Sabeta Clemens Gruber Anthony R. Fooks Rachel K. Chikwamba Julian K-C. Ma

Rabies post-exposure prophylaxis (PEP) currently comprises administration of rabies vaccine together with rabies immunoglobulin (RIG) of either equine or human origin. In the developing world, RIG preparations are expensive, often in short supply, and of variable efficacy. Therefore, we are seeking to develop a monoclonal antibody cocktail to replace RIG. Here, we describe the cloning, engineer...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید